HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
SM-216601
exhibits potent activity against methicillin-resistant staphylococci (MRS) and vancomycin-resistant enterococci (VRE); structure in first source
Networked:
1
relevant articles (
1
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Organic Chemicals: 133
Amides: 2428
Lactams: 2198
beta-Lactams: 2386
Carbapenems: 4837
SM-216601: 1
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
beta-Lactams: 2386
Carbapenems: 4837
SM-216601: 1
Experts
1.
Eguchi, Ken
: 1 article (10/2005)
2.
Eriguchi, Yoshiro
: 1 article (10/2005)
3.
Kanazawa, Katsunori
: 1 article (10/2005)
4.
Sunagawa, Makoto
: 1 article (10/2005)
5.
Takemoto, Koji
: 1 article (10/2005)
6.
Ueda, Yutaka
: 1 article (10/2005)
Related Diseases
1.
Infections
10/01/2005 - "
The therapeutic efficacy of SM-216601 against experimentally induced infections in mice caused by S.
"
2.
Bacterial Infections (Bacterial Infection)
10/01/2005 - "
Thus, SM-216601 is a promising candidate for nosocomial bacterial infections caused by a wide range of gram-positive and gram-negative bacteria, including multiresistant pathogens.
"